These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10785559)

  • 1. Substituted 1,2,3-triazolo[1,5-a]quinazolines: synthesis and binding to benzodiazepine and adenosine receptors.
    Bertelli L; Biagi G; Giorgi I; Livi O; Manera C; Scartoni V; Lucacchini A; Giannaccini G; Barili PL
    Eur J Med Chem; 2000 Mar; 35(3):333-41. PubMed ID: 10785559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New 1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. II.
    Biagi G; Giorgi I; Livi O; Scartoni V; Betti L; Giannaccini G; Trincavelli ML
    Eur J Med Chem; 2002 Jul; 37(7):565-71. PubMed ID: 12126775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists.
    Francis JE; Cash WD; Psychoyos S; Ghai G; Wenk P; Friedmann RC; Atkins C; Warren V; Furness P; Hyun JL
    J Med Chem; 1988 May; 31(5):1014-20. PubMed ID: 3361572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations.
    Biagi G; Giorgi I; Livi O; Scartoni V; Velo S; Lucacchini A; Senatore G; De Santis B; Martinelli A
    Farmaco; 1996 Feb; 51(2):131-6. PubMed ID: 8857209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
    Betti L; Biagi G; Giannaccini G; Giorgi I; Livi O; Lucacchini A; Manera C; Scartoni V
    J Med Chem; 1998 Feb; 41(5):668-73. PubMed ID: 9513594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones.
    Francis JE; Cash WD; Barbaz BS; Bernard PS; Lovell RA; Mazzenga GC; Friedmann RC; Hyun JL; Braunwalder AF; Loo PS
    J Med Chem; 1991 Jan; 34(1):281-90. PubMed ID: 1846920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.
    Catarzi D; Colotta V; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    Farmaco; 2004 Feb; 59(2):71-81. PubMed ID: 14871498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and preliminary use of 1-, 2- and 3-methyl-5-phenyl-7-chloro-1,2,3-triazolo[4,5-d]pyrimidine as reaction intermediates.
    Biagi G; Giorgi I; Livi O; Scartoni V; Barili PL
    Farmaco; 2003 Aug; 58(8):551-6. PubMed ID: 12875884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-substituted 4-[chloropyrazolyl][1,2,4]triazolo[4,3-a]quinoxalines: synthesis and structure-activity relationships of a new class of benzodiazepine and adenosine receptor ligands.
    Matuszczak B; Pekala E; Müller CE
    Arch Pharm (Weinheim); 1998 May; 331(5):163-9. PubMed ID: 9691247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricyclic heteroaromatic systems. 2-Phenyl-1,2,4-triazolo[1,5-c][1,3]benzoxazin-5-one: a novel benzodiazepine receptor ligand.
    Catarzi D; Cecchi L; Colotta V; Filacchioni ; Martini C; Giusti L; Lucacchini A; Valle G
    Farmaco; 1994 Feb; 49(2):89-92. PubMed ID: 8003185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,2,3-Triazole[4,5-d]pyridazines--II. New derivatives tested on adenosine receptors.
    Biagi G; Giorgi I; Livi O; Scartoni V; Martini C; Tacchi P; Merlino S; Pasero M
    Farmaco; 1994 Mar; 49(3):175-81. PubMed ID: 8043168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 4-amino-6-(hetero)arylalkylamino-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent A(2A) adenosine receptor antagonists.
    Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    Bioorg Med Chem; 2003 Dec; 11(24):5509-18. PubMed ID: 14642595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Amino[1,2,4]triazolo[1,5-c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure-Activity Relationships of Potent Adenosine Receptor Antagonists.
    Burbiel JC; Ghattas W; Küppers P; Köse M; Lacher S; Herzner AM; Kombu RS; Akkinepally RR; Hockemeyer J; Müller CE
    ChemMedChem; 2016 Oct; 11(20):2272-2286. PubMed ID: 27531666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
    Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK
    J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricyclic heteroaromatic systems 1,2,4-triazolo[1,5-a]quinoxalines: synthesis and benzodiazepine receptor activity.
    Catarzi D; Cecchi L; Colotta V; Melani F; Filacchioni G; Martini C; Giusti L; Lucacchini A
    Farmaco; 1993 Aug; 48(8):1065-78. PubMed ID: 8216669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of 4-cycloalkylamino-1, 2, 4-triazolo[4, 3-a]quinoxalin-1- one derivatives as A1 and A3 adenosine receptor antagonists.
    Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A; Colotta V
    Arch Pharm (Weinheim); 2004 Jan; 337(1):35-41. PubMed ID: 14760626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2,3-triazole[4,5-d]pyridazines. III--Synthesis of new 4-amino derivatives and their affinity toward adenosine receptors.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Senatore G; Barili PL
    Farmaco; 1994 May; 49(5):357-62. PubMed ID: 8080619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on specific inhibition of benzodiazepine receptor binding by some C-benzoyl-1,2,3-triazole derivatives.
    Biagi G; Giorgi I; Livi O; Lucacchini A; Martini C; Scartoni V
    J Pharm Sci; 1993 Sep; 82(9):893-6. PubMed ID: 8229686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,2,4-Triazolo[5,1-i]purine derivatives as highly potent and selective human adenosine A(3) receptor ligands.
    Okamura T; Kurogi Y; Nishikawa H; Hashimoto K; Fujiwara H; Nagao Y
    J Med Chem; 2002 Aug; 45(17):3703-8. PubMed ID: 12166943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.